Literature DB >> 20057364

Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding.

Mousumi Bose1, Sriram Machineni, Blanca Oliván, Julio Teixeira, James J McGinty, Baani Bawa, Ninan Koshy, Antonia Colarusso, Blandine Laferrère.   

Abstract

The goal of this study was to understand the mechanisms of greater weight loss by gastric bypass (GBP) compared to gastric banding (GB) surgery. Obese weight- and age-matched subjects were studied before (T0), after a 12 kg weight loss (T1) by GBP (n = 11) or GB (n = 9), and at 1 year after surgery (T2). peptide YY(3-36) (PYY(3-36)), ghrelin, glucagon-like peptide-1 (GLP-1), leptin, and amylin were measured after an oral glucose challenge. At T1, glucose-stimulated GLP-1 and PYY levels increased significantly after GBP but not GB. Ghrelin levels did not change significantly after either surgery. In spite of equivalent weight loss, leptin and amylin decreased after GBP, but not after GB. At T2, weight loss was greater after GBP than GB (P = 0.003). GLP-1, PYY, and amylin levels did not significantly change from T1 to T2; leptin levels continued to decrease after GBP, but not after GB at T2. Surprisingly, ghrelin area under the curve (AUC) increased 1 year after GBP (P = 0.03). These data show that, at equivalent weight loss, favorable GLP-1 and PYY changes occur after GBP, but not GB, and could explain the difference in weight loss at 1 year. Mechanisms other than weight loss may explain changes of leptin and amylin after GBP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057364      PMCID: PMC2877144          DOI: 10.1038/oby.2009.473

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  47 in total

1.  Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.

Authors:  May Faraj; Peter J Havel; Steve Phélis; David Blank; Allan D Sniderman; Katherine Cianflone
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

Authors:  David E Cummings; David S Weigle; R Scott Frayo; Patricia A Breen; Marina K Ma; E Patchen Dellinger; Jonathan Q Purnell
Journal:  N Engl J Med       Date:  2002-05-23       Impact factor: 91.245

4.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

5.  Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

Authors:  Antonio E Pontiroli; Pierluigi Pizzocri; Maria Cristina Librenti; Paola Vedani; Monica Marchi; Emanuele Cucchi; Corrado Orena; Michele Paganelli; Maurizio Giacomelli; Gianfranco Ferla; Franco Folli
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

6.  Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans.

Authors:  Camilla Holdstock; Britt Edén Engström; Margareta Ohrvall; Lars Lind; Magnus Sundbom; F Anders Karlsson
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

8.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

9.  Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.

Authors:  Rolf Stoeckli; Robin Chanda; Igor Langer; Ulrich Keller
Journal:  Obes Res       Date:  2004-02

10.  Short-term effects of gastric bypass surgery on circulating ghrelin levels.

Authors:  Rosa Morínigo; Roser Casamitjana; Violeta Moizé; Antonio M Lacy; Salvadora Delgado; Ramon Gomis; Josep Vidal
Journal:  Obes Res       Date:  2004-07
View more
  47 in total

1.  Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery.

Authors:  C N Ochner; E Stice; E Hutchins; L Afifi; A Geliebter; J Hirsch; J Teixeira
Journal:  Neuroscience       Date:  2012-02-24       Impact factor: 3.590

Review 2.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

3.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms.

Authors:  Sean Manning; Andrea Pucci; Rachel L Batterham
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

Review 6.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

7.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

8.  Preparation of a severely obese adolescent for significant and long-term weight loss: an illustrative case.

Authors:  Andrew J Kruger; Kathleen B Hrovat; Stavra A Xanthakos; Thomas H Inge
Journal:  Pediatr Surg Int       Date:  2013-04-16       Impact factor: 1.827

Review 9.  A screening tool to assess and manage behavioral risk in the postoperative bariatric surgery patient: The WATCH.

Authors:  Janelle W Coughlin; Angela S Guarda; Jeanne M Clark; Margaret M Furtado; Kimberley E Steele; Leslie J Heinberg
Journal:  J Clin Psychol Med Settings       Date:  2013-12

Review 10.  Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.

Authors:  Rodrigo Muñoz; Alex Escalona
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.